Related by context. Frequent words. (Click for all words.) 87 Phase III Clinical Trial 85 Clinical Trial Results 85 Patient Enrollment 83 Pivotal Trial 83 Completes Enrollment 83 Drug Candidate 80 Pivotal Phase III 80 Patients Treated 79 Pivotal Phase 78 Presents Positive 78 Metastatic Colorectal Cancer 78 FDA Accepts 77 Preclinical Data 77 Monotherapy 76 Clinical Study 76 Metastatic Melanoma 76 Study Demonstrates 75 Generic Version 75 FDA Clears 75 Heart Failure Patients 75 FDA Approves 74 Elderly Patients 74 Positive Opinion 74 Pulmonary Arterial Hypertension 74 Cholesterol Drug 74 Significantly Reduces 74 Chronic Hepatitis C 74 Clinical Trial 74 Overactive Bladder 73 Combination Therapy 73 Receives FDA Clearance 73 Prostate Cancer Patients 73 Initiates Phase 73 Advanced Prostate Cancer 72 Low Dose 72 Tolerability 72 RNAi Therapeutics 72 Monoclonal Antibody 71 Acute Myocardial Infarction 71 Postmenopausal Women 71 Announces Initiation 71 Chronic Lymphocytic Leukemia 71 Cardiovascular Events 71 Announces Presentation 70 FDA Clearance 70 Reduces Risk 70 Shows Promise 70 Pirfenidone 70 Epratuzumab 70 Enoxaparin 70 Meta Analysis 70 Extended Release 70 Prostate Cancer Treatment 70 Drug Eluting Stent 69 Cethromycin 69 Drug Eluting Stents 69 Relapsed 69 Benign Prostatic Hyperplasia 69 Small Molecule 69 Breast Cancer Treatment 69 FDA Approval 69 Cancer Treatments 69 Smallpox Vaccine 68 Orphan Drug Status 68 Bevacizumab 68 Irinotecan 68 Ofatumumab 68 Increases Risk 68 Lenalidomide 68 Inhibits 68 Multicenter 68 KRN# 68 Hormone Therapy 68 Pharmacokinetic 68 Solid Tumors 68 Amrubicin 68 Announces Publication 68 Study Confirms 67 Breast Cancer Patients 67 Alemtuzumab 67 Cancer Vaccine 67 Hepatitis C Virus 67 Clinical Outcomes 67 Bortezomib 67 Achieves Milestone 67 Coronary Stent 67 Increased Risk 67 Reports Positive 67 Genasense R 67 Randomized Controlled Trial 67 Insulin Resistance 67 Diet Pill 67 Dialysis Patients 67 Commercialize 66 Announces Positive 66 Non Invasive 66 Successful Completion 66 Rivaroxaban 66 Cell Lung Cancer 66 Atopic Dermatitis 66 phase IIb clinical